Intelligent hydrogels for the oral delivery of chemotherapeutics

Bibliography

• FENG SS, CHIEN S: Chemotherapeutic engineering application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem. Eng. Sci. (2003) 58:4087–4114.
   Google Scholar
• •A good overview of engineering approaches to chemotherapeutic systems.
   Google Scholar
• J A, TAKIUCHI H: Recent developments in oral chemotherapy options for gastric carcinoma. Drugs (1999) 58:85–90.
   Google Scholar
• DEMARIO MD, RATAIN MJ: Oral chemotherapy rationale and future directions. " Chu. Oncol (1999) 16(7):2557–2567.
   Google Scholar
• BOTTOMLEY A: The cancer patient and quality of life. Oncologist (2002) 7:120–125.
   Google Scholar
• BLANCHETTE J, KAVIMANDAN N, PEPPAS NA: Principles of transmucosal delivery of therapeutic agents. Biomed. Pharmacother. (2004) 58(3):142–151.
   Google Scholar
• LORENCE A, NESSLER CL: Camptothecin, over four decades of surprising findings. Phytochemistry (2004) 65(20):2735–2749.
   Google Scholar
• MURPHY BA: Topoisomerases in the treatment of metastatic or recurrent squamous carcinoma of the head and neck. Expert Opin. Pharmacother. (2005) 6(0:85–92.
   Google Scholar
• BERAN M, O'BRIEN S, THOMAS DA et al.: Phase I Study of oral topotecan in hematological malignancies. Chu. Cancer Res. (2003) 9(10:4084–4091.
   Google Scholar
• SCHELLENS JH, CREEMERS GJ, BEIJNEN JH et al.: Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor. Br. J. Cancer (1996) 73(10):1268–1271.
   Google Scholar
• PAWEL J, GATZEMEIER U, PUJOL JL et al.: Phase II comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung canicerj Clin. Oncol (2001) 19:1743–1749.
   Google Scholar
• GELDERBLOM H, VERWEIJ J, NOOTER K, SPARREBOOM A: Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer (2001) 37(13):1590–8159.
   Google Scholar
• MALINGRE MM, SCHELLENS JH, VAN TELLINGEN 0 et al: The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients. Br. J. Cancer (2001) 85(10):1472–1477.
   Google Scholar
• DIAZ R, SEGURA A, APARICIO J, CALDERERO V, GUERRERO A, PELLIN L: Lethal toxicity after 5-fluorouracil chemotherapy and its possible relationship to dihydropyrimidine dehydrogenase deficiency: a case report and review of the literature. J. Chemother. (2004) 16(6):599–603.
   Google Scholar
• SCHILSKY RL, LEVIN J, WEST WH et al: Randomized, open-label, Phase III study of a 28-day oral regimen of eniluracil plus fluorouracil versus intravenous fluorouracil plus leucovorin as first-line therapy in patients with metastatic/ advanced colorectal cancer." Chu. Oncol (2002) 20(6):1519–1526.
   Google Scholar
• BAKER SD: Pharmacology of fluorinated pyrimidines: eniluracil. Invest. New Drugs (2000) 18(4):373–381.
   Google Scholar
• NUKATSUKA M, FUJIOKA A, NAKAGAWA F et al: Antimetastatic and anticancer activity of 5-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer model. IriL Oncol (2004) 25(6):1531–1536.
   Google Scholar
• KANARD A, JATOI A, CASTILLO R et al: Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a Phase II trial of efficacy and toxicity. Lung Cancer (2004) 43(3):345–353.
   Google Scholar
• GRIDELLI C, MANEGOLD C, MALI P et al: Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre Phase II trial. Eur. J. Cancer (2004) 40(16):2424–2431.
   Google Scholar
• ROGERS JA, ANDERSON KE: The potential of liposomes in oral drug delivery. Crit. Rev Ther. Drug Carrier Syst. (1998) 15(5):421–480.
   Google Scholar
• WIN K, FENG SS: Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials (2005) 26(15):2713–2722.
   Google Scholar
• BLANCHETTE J, PEPPAS NA: Cellular evaluation of oral chemotherapy carriers. Biomed. Mater. Res. Part A (2005) 72A(4):381–388.
   Google Scholar
• •One of the first reports on the delivery of chemotherapeutics using responsive copolymers.
   Google Scholar
• BLANCHETTE J, PEPPAS NA: Oral chemotherapeutic delivery: design and cellular response. Ann. Biomed. Eng. (2005) 33(2):142–149.
   Google Scholar
• BROMBERG L: Intelligent polyelectrolytes and gels in oral drug delivery. Curr. Pharm. Biotechnol (2003) 4(5):339–349.
   Google Scholar
• •An overview of intelligent hydrogels for oral drug delivery.
   Google Scholar
• HAEBERLIN B, FRIEND DR: In: Oral Colon-Specific Drug Delivery DR Friend (Ed.), CRC Press, Boca Raton, FL, USA (1992):1–44.
   Google Scholar
• CHOURASIA MK, JAIN SK: Design and development of multiparticulate system for targeted drug delivery to colon. Drug Deify. (2004) 11(3):201–207.
   Google Scholar
• PEPPAS NA, WOOD KM, BLANCHETTE JO: Hydrogels for oral delivery of therapeutic proteins. Expert Opin. Biol. Ther. (2004) 4(6):881–887.
   Google Scholar
• GABIZON A, SHMEEDA H, BARENHOLZ Y: Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Chu. Pharmacokinet. (2003) 42(5):419–436.
   Google Scholar
• BROMBERG L: Hydrophobically modified polyelectrolytes and polyelectrolyte block-copolymers. In: Handbook of Surfaces and Interfaces of Materials (Volume 4).• Solid Thin Films and Layers. HS Nalwa (Ed.), Academic Press, San Diego, CA, USA (2000369–404.
   Google Scholar
• BROMBERG L: Hydrophobically modified polyelectrolytes and polyelectrolyte block-copolymers for biomedical applications. (Chapter 51). In: Handbook of Polyelectrolytes and Their Applications.SK T J K HS Nalwa (Eds), American Scientific Publishers, Los Angeles, CA, USA (2002):23–46.
   Google Scholar
• BROMBERG L, TEMCHENKO M, ALAKHOV V, HATTON TA: Bioadhesive properties and rheology of polyether-modified poly(acrylic acid) hydrogels. Int.j Pharm. (2004) 282(1-2):45–60.
   Google Scholar
• •An in-depth description of the mechanism of bioadhesion by Pluronic-PAA hydrogels.
   Google Scholar
• BROMBERG L, TEMCHENKO M, HATTON TA: Dually responsive microgels from polyether-modified poly(acrylic acid): swelling and drug loading. Langmuir (2002) 18(12):4944–4952.
   Google Scholar
• ••The first description of loading chemotherapeutic drugs into intelligent Pluronic-PAA microgels.
   Google Scholar
• BROMBERG L, TEMCHENKO M, HATTON TA: Smart microgel studies. Polyelectrolyte and drug-absorbing properties of microgels from polyether-modified poly(acrylic acid). Langmuir (2003) 19(21):8675–8684.
   Google Scholar
• BROMBERG L, TEMCHENKO M, MOESER GD, HATTON TA: Thermodynamics of temperature-sensitive polyether-modified poly(acrylic acid) microgels. Langmuir (2004) 20(14):5683–5692.
   Google Scholar
• BROMBERG L, TEMCHENKO M, ALAKHOV V, HATTON TA: Kinetics of swelling of polyether-modified poly(acrylic acid) microgels with permanent and degradable cross-links. Langmuir (2005) 21(4):1590–1598.
   Google Scholar
• BARREIRO-IGLESIAS R, BROMBERG L, TEMCHENKO M, HATTON TA, CONCHEIRO A, ALVAREZ-LORENZO C: Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers. ./. Control. Release (2004) 97(3)537–549.
   Google Scholar
• BROMBERG LE, BARR DP: Aggregation phenomena in aqueous solutions of hydrophobically modified polyelectrolytes. A probe solubilization study. Macromolecules (1999) 32(11):3649–3657.
   Google Scholar
• BROMBERG L, TEMCHENKO M: Loading of hydrophobic compounds into micellar solutions of hydrophobically modified polyelectrolytes. Langmuir (1999) 15(25):8627–8632.
   Google Scholar
• HUIBERS PD, BROMBERG LE, ROBINSON BH, HATTON TA: Reversible gelation in semidilute aqueous solutions of associative polymers: a small-angle neutron scattering study. Macromolecules (1999) 32(15):4889–4894.
   Google Scholar
• BROMBERG L: Interactions among proteins and hydrophobically modified polyelectrolytes. Pharm. Pharmacol. (2001) 53(4):541–547.
   Google Scholar
• FASSBERG J, STELLA VJ: A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. Pharm. Sci. (1992) 81:676–684.
   Google Scholar
• BROMBERG LE, RON ES: Protein and peptide release from temperature-responsive gels and thermogelling polymer matrices. Adv. Drug Deily. Rev (1998) 31(3):197–221.
   Google Scholar
• BASF Performance Chemicals. FDA and EPA status. BASF Corporation, North Mount Olive, NJ, USA (1993):234.
   Google Scholar
• Final Assessment Report of the Safety of Carbomers 934, -934P, -940, -941 and -962.1 Am. Coll Toxicol. (1982) 1:109–141.
   Google Scholar
• BROMBERG L, ALAKHOV V: Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell layers. J. Control. Release (2003) 88(1):11–22.
   Google Scholar
• •The first study of cellular chemotherapeutic drug transport enhancement using microgels of Pluronic-PAA.
   Google Scholar
• BATRAKOVA EV, LI S, D W, KABANOV AV: Pluronic P85 increases permeability of a broad Spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm. Res. (1999) 16(9):1366–1372.
   Google Scholar
• BATRAKOVA EV, LI S, VINOGRADOV SV et al: Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization.' Pharmacol. Exp. Ther. (2001) 299(2):483–493.
   Google Scholar
• ALAKHOV V, KLINSKI E, LI S et al: Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Surf B: Biointerfaces (1999) 16:113–134.
   Google Scholar
• CLEARY J, BROMBERG L, MAGNER E:Adhesion of polyether-modified poly(acrylic acid) to mucin. Langmuir (2004) 20(22):9755–9762.
   Google Scholar
• ALAKHOV V, PIETRZYNSKI G, PATEL K, KABANOV A, BROMBERG L, HATTON TA: Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate. J. Pharm. Pharmacol. (2004) 56(10):1233–1241.
   Google Scholar
• •The first in vivo study of the oral dosage forms using intelligent Pluronic-PAA microgels.
   Google Scholar
• BERKNOP-SCHNORCH A, HOFFER MH, KEFEDJIISKI K: Thiomers for oral delivery of hydrophilic macromolecular drugs. Expert Opin. Drug Deify. (2004) 1(1):87–98.
   Google Scholar
• •An insightful review of the thiolated polymers for oral drug delivery.
   Google Scholar